Lago AA, Parada TMG, Somera IJ

Language: Spanish
References: 20
Page: 261-266
PDF size: 200.00 Kb.

ABSTRACT

Background: In Mexico there isn’t accurate epidemiologic information of osteoporosis prevalence, however it is estimated that 24.5 million people are at risk or suffer it yet.
Objective: To show prevalence of osteoporosis in open population of several areas of Mexico City.
Patients and method: Retrospective, transversal and open study at an osseous densitometric data base information from 5,924 patients.
Results: Densitometry evidence that 17.9% suffer osteoporosis (79.8 female and 20.1% male), 34.5% osteopeny (76.1 female and 23.8 female), and 47.4% had normal bones (75.8% female and 24.1% female).
Conclusions: Since osseous mineral density changes exponentially increases with age, osteopenic and osteoporosis index is very high after 40 years old; due to that there must be considered preventative programs for young groups, and to practice densitometries to 30 year old men and women.

REFERENCES

1. International Osteoporosis Foundation (OIF). [sitio en línea: http://www.iofbonehealth.org]

2. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporosis fractures. Lancet 2002;359(9319):1761-7.

3. Valdivia CG, Szot MJ. Epidemiología de la osteoporosis. Bol Esc Med Univ Cat Chile 1999;1-2(28):28.

4. Kurth AA, Pfeilschifter J. Diagnosis and treatment of postmenopausal osteoporosis and osteoporosis in men. German Guidelines Updates 2006. Ortophade 2007;36(7):683-92.

5. Grampp S, Henk CB, Imhof H. Clinical application of densitometry. Radiologe 1999;39(3):222-7.

6. Melton LJ 3rd, Thamer M, Ray NF, Chan JK, et al. Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res 1997;12(1):16-23.

7. Melton U, Chrischilles EA, Cooper C, Lane AW, Riggs BL. How many women have osteoporosis? J Bone Miner Res 1992;7(9):1005-10.

8. South-Paul JE. Osteoporosis: part I. Evaluation and assessment. Am Fam Physician 2001;63(5):897-904.

9. Finkelstein JS, Klibanski A, Arnold AL, Toth TL, et al. Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial. JAMA 1998;280(12):1067-73.

10. Mendoza RM, Escalante PJ, Martínez ZR, Ramírez AM. Osteoporosis en mexicanas mayores de 40 años. Determinaciones por densitometría periférica. Rev Med IMSS 2003;41(3):193-202.

11. World Health Organization. Assessment of fracture risk and its application to screening for posmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994;843:1-129.

12. Blake GM, Fogelman I. Applications of bone densitometry for osteoporosis. Endocrinol Metb Clin North Am 1998;27(2):267-88.

13. Blake GM, Fogelman I. Bone densitometry and diagnosis of osteoporosis. Semin Nucl Med 2001;31(1):69-81.

14. Terrés SAM, Tamayo JA, Valle SO. Edad ósea: estimación densitométrica y metabólica. Rev Mex Patol Clin 2002;49(1):7-14.

15. Melton LJ 3rd. Epidemiology of spinal osteoporosis. Spine 1997;15(24 Suppl):2S-11S.

16. Murillo UA, Deleze HM. Osteoporosis en mujeres posmenopáusicas mexicanas. Magnitud del problema. Estudio multicéntrico. Ginecol Obstet Mex 1999;67:227-33.

17. Díaz-Curiel M, García JJ, Carrasco JL, Honorato J y col. Prevalencia de osteoporosis determinada por densitometría en población la femenina española. Med Clin (Barc) 2001;116(3):86-88.

18. Grampp S, Henk CB, Imhof H. Bone densitometry: comparative value and limitations of different techniques. Wien Med Wochenschr 1999;149(16-17):472-8.

19. Villegas CH, Mayon GJ. Radiológico, densitométrico, morfológico y estudio de microscopia electrónica de osteoporosis y osteopenia en la tercera vértebra lumbar en hombres y mujeres de la Ciudad de México. Ginecol Obstet Mex 1998;66:187-201.

20. Blake GM, Fogelman I. Dual energy x-ray absorptiometry and its clinical applications. Semin Musculoskelet Radiol 2002;6(3):207-18.